YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Share Price
Equities
1558
CNE1000023R6
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.8 HKD | +2.40% |
|
+3.56% | +34.88% |
| 09/04 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
| 01/04 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
| Sales 2024 * | 6.6B 910M 7.13B 75.9B | Sales 2025 * | 6.71B 926M 7.25B 77.17B | Capitalization | 10.43B 1.44B 11.26B 120B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.58 x |
| Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 1.55 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
8.44% | Yield 2025 * |
8.27% | Free-Float | 27.7% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.40% | ||
| 1 week | +3.56% | ||
| Current month | +17.65% | ||
| 1 month | +18.30% | ||
| 3 months | +53.66% | ||
| 6 months | +72.97% | ||
| Current year | +34.88% |
1 week
11.88
12.82
1 month
10.0613.04
Current year
7.9113.04
1 year
6.0213.04
3 years
3.3513.04
5 years
3.3527.23
10 years
3.3527.23
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Cai Jiang
CEO | Chief Executive Officer | 42 | 04/15/04 |
Qiang Zhang
DFI | Director of Finance/CFO | 49 | 23/18/23 |
Hao Chen
BRD | Director/Board Member | 49 | 01/09/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Fa Tang
CHM | Chairman | 54 | 04/15/04 |
Jun Cai Jiang
CEO | Chief Executive Officer | 42 | 04/15/04 |
Dan Jin Wang
BRD | Director/Board Member | 54 | 27/06/27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.22% | 4 M€ | -27.92% | ||
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 12.8 | +2.40% | 1,989,200 |
| 25/24/25 | 12.5 | +3.48% | 2,244,600 |
| 24/24/24 | 12.08 | 0.00% | 1,646,800 |
| 23/24/23 | 12.08 | +1.00% | 1,695,600 |
| 22/24/22 | 11.96 | -3.24% | 2,140,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST
More quotes
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceutical products. The Company is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and metabolic drugs and cardiovascular drugs. Its main products include Kewei, Ertongshu, Oumeining, Xinhaining and Xining.
Sector
Pharmaceuticals
Calendar
23/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.85
CNY
Average target price
12.94
CNY
Spread / Average Target
+9.22%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +34.88% | 1.44B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 1558 Stock
